The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Drugs with anticholinergic effects and cognitive impairment, falls and all‐cause mortality in older adults: A systematic review and meta‐analysis
Open accessAbstract
Aim: The aim was to investigate associations between drugs with anticholinergic effects (DACEs) and cognitive impairment, falls and all‐cause mortality in older adults. Methods: A literature search using CINAHL, Cochrane Library, Embase and PubMed databases was conducted for randomized controlled trials, prospective and retrospective cohort and case‐control studies examining the use of DACEs in subjects ≥65 years with outcomes on falls, cognitive impairment and all‐cause mortality. Retrieved articles were published on or before June 2013. Anticholinergic exposure was investigated using drug class, DACE scoring systems (anticholinergic cognitive burden scale, ACB; anticholinergic drug scale, ADS; anticholinergic risk scale, ARS; anticholinergic component of the drug burden index, DBI AC) or assessment of individual DACEs. Meta‐analyses were performed to pool the results from individual studies. Results: Eighteen studies fulfilled the inclusion criteria (total 124 286 participants). Exposure to DACEs as a class was associated with increased odds of cognitive impairment (OR 1.45, 95% CI 1.16, 1.73). Olanzapine and trazodone were associated with increased odds and risk of falls (OR 2.16, 95% CI 1.05, 4.44; RR 1.79, 95% CI 1.60, 1.97, respectively), but amitriptyline, paroxetine and risperidone were not (RR 1.73, 95% CI 0.81, 2.65; RR 1.80, 95% CI 0.81, 2.79; RR 1.39, 95% CI 0.59, 3.26, respectively). A unit increase in the ACB scale was associated with a doubling in odds of all‐cause mortality (OR 2.06, 95% CI 1.82, 2.33) but there were no associations with the DBI AC (OR 0.88, 95% CI 0.55, 1.42) or the ARS (OR 3.56, 95% CI 0.29, 43.27). Conclusions: Certain individual DACEs or increased overall DACE exposure may increase the risks of cognitive impairment, falls and all‐cause mortality in older adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
(2014) · Medical Entomology and Zoology · Cited by 17,633
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Hastings, R. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540120077042 · Cited by 2,371
Mangoni, A. A., & Jackson, S. H. D. (2004) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.02007.x · Cited by 1,874
Self-citationSchneider, L. S., Dagerman, K., & Insel, P. S. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000200589.01396.6d · Cited by 903
Impact of Anticholinergics on the Aging Brain: A Review and Practical Application
Boustani, M., Campbell, N., Munger, S., Maidment, I., & Fox, C. (2008) · Aging Health · doi:10.2217/1745509x.4.3.311 · Cited by 862
The anticholinergic risk scale and anticholinergic adverse effects in older persons
Rudolph, J. L. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.106 · Cited by 835
A Drug Burden Index to Define the Functional Burden of Medications in Older People
Hilmer, S. N. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.8.781 · Cited by 759
Carnahan, R. M., Lund, B. C., Perry, P. J., Pollock, B. G., & Culp, K. R. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006292126 · Cited by 664
Fox, C., Richardson, K., Maidment, I. D., Savva, G. M., Matthews, F. E., Smithard, D., Coulton, S., Katona, C., Boustani, M. A., & Brayne, C. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03491.x · Cited by 655
Ancelin, M. L., Artero, S., Portet, F., Dupuy, A.-M., Touchon, J., & Ritchie, K. (2006) · BMJ · doi:10.1136/bmj.38740.439664.de · Cited by 589
Millan, M. J., Maiofiss, L., Cussac, D., Audinot, V., Boutin, J.-A., & Newman-Tancredi, A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039867 · Cited by 484
Han, L., McCusker, J., Cole, M., Abrahamowicz, M., Primeau, F., & Élie, M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.8.1099 · Cited by 446
Antidepressants and the Risk of Falls among Nursing Home Residents
Thapa, P. B., Gideon, P., Cost, T. W., Milam, A. B., & Ray, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391303 · Cited by 439
Polypharmacy and falls in the middle age and elderly population
Ziere, G., Dieleman, J. P., Hofman, A., Pols, H. A. P., Van Der Cammen, T. J. M., & Stricker, B. H. C. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02543.x · Cited by 420
Carrière, I., Fourrier-Reglat, A., Dartigues, J.-F., Rouaud, O., Pasquier, F., Ritchie, K., & Ancelin, M.-L. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.229 · Cited by 374
Fox, C., Smith, T., Maidment, I., Chan, W.-Y., Bua, N., Myint, P. K., Boustani, M., Kwok, C. S., Glover, M., Koopmans, I., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu096 · Cited by 336
Anticholinergic side-effects of drugs in elderly people
Mintzer, J., & Burns, A. (2000) · Journal of the Royal Society of Medicine · doi:10.1177/014107680009300903 · Cited by 322
Drug Burden Index Score and Functional Decline in Older People
Hilmer, S. N., Mager, D. E., Simonsick, E. M., Ling, S. M., Windham, B. G., Harris, T. B., Shorr, R. I., Bauer, D. C., & Abernethy, D. R. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.02.021 · Cited by 254
Tannenbaum, C., Paquette, A., Hilmer, S., Holroyd-Leduc, J., & Carnahan, R. (2012) · Drugs & Aging · doi:10.1007/bf03262280 · Cited by 241
Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis
Barr, R. G. (2006) · Thorax · doi:10.1136/thx.2006.063271 · Cited by 236
Singh, S., Loke, Y. K., Enright, P. L., & Furberg, C. D. (2011) · BMJ · doi:10.1136/bmj.d3215 · Cited by 227
Kay, G. G., Abou‐Donia, M. B., Messer, W. S., Murphy, D. G., Tsao, J. W., & Ouslander, J. G. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.00537.x · Cited by 226
Berdot, S., Bertrand, M., Dartigues, J.-F., Fourrier, A., Tavernier, B., Ritchie, K., & Alpérovitch, A. (2009) · BMC Geriatrics · doi:10.1186/1471-2318-9-30 · Cited by 226
Use of anticholinergics and the risk of cognitive impairment in an African American population
Campbell, N. L., Boustani, M. A., Lane, K. A., Gao, S., Hendrie, H., Khan, B. A., Murrell, J. R., Unverzagt, F. W., Hake, A., Smith-Gamble, V., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e7f2ab · Cited by 194
Cao, Y.-J., Mager, D., Simonsick, E., Hilmer, S., Ling, S., Windham, B., Crentsil, V, Yasar, S., Fried, L., & Abernethy, D. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100303 · Cited by 188
Coupland, C. A. C., Dhiman, P., Barton, G., Morriss, R. K., Arthur, A. J., Sach, T., & Hippisley‐Cox, J. (2011) · Health Technology Assessment · doi:10.3310/hta15280 · Cited by 148
Dong, Y., Lin, H.-H., Shau, W., Wu, Y., Chang, C., & Lai, M. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-201926 · Cited by 140
Atypical Antipsychotic Medications and Risk of Falls in Residents of Aged Care Facilities
Hien, L. T. T., Cumming, R. G., Cameron, I. D., Chen, J. S., Lord, S. R., MARCH, L. M., Schwarz, J., Couteur, D. G. L., & Sambrook, P. N. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53403.x · Cited by 134
Lackner, T. E., Wyman, J. F., McCarthy, T. C., Monigold, M., & Davey, C. S. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01680.x · Cited by 126
Sarter, M. F., Albin, R. L., Kucinski, A. J., & Lustig, C. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.032 · Cited by 125
Mangoni, A. A., Munster, B. C. V., Woodman, R. J., & de Rooij, S. E. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.012 · Cited by 106
Self-citationQuality use of medicines in residential aged care.
Somers, M., Rose, E., Simmonds, D., Whitelaw, C., Alan, J., & Etherton‐Beer, C. (2010) · PubMed · Cited by 99
Lowry, E., Woodman, R. J., Soiza, R. L., & Mangoni, A. A. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.03.006 · Cited by 92
Self-citationDrug Burden Index, Physical Function, and Adverse Outcomes in Older Hospitalized Patients
Lowry, E., Woodman, R. J., Soiza, R. L., Hilmer, S. N., & Mangoni, A. A. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011421489 · Cited by 91
Self-citationThe cholinergic system, sigma-1 receptors and cognition
van Waarde, A., Ramakrishnan, N. K., Rybczynska, A. A., Elsinga, P. H., Ishiwata, K., Nijholt, I. M., Luiten, P. G. M., & Dierckx, R. A. J. O. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.043 · Cited by 90
Deconditioning in the hospitalized elderly.
Gillis, A. J., & MacDonald, B. L. (2005) · PubMed · Cited by 76
All‐cause mortality associated with atypical and typical antipsychotics in demented outpatients
Trifirò, G., Verhamme, K. M. C., Ziere, G. J., Caputi, A. P., Stricker, B. H. C., & Sturkenboom, M. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1334 · Cited by 75
Anticholinergic Drugs and Their Effects on Delirium and Mortality in the Elderly
Luukkanen, M. J., Uusvaara, J., Laurila, J., Strandberg, T. E., Raivio, M., Tilvis, R. S., & Pitkälä, K. H. (2011) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000322883 · Cited by 63
Anticholinergic Drugs in Late Life: Adverse Effects on Cognition but not on Progress to Dementia
Whalley, L. J., Sharma, S., Fox, H. C., Murray, A. D., Staff, R. T., Duthie, A. C., Deary, I. J., & Starr, J. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-110935 · Cited by 59
Uusvaara, J., Pitkälä, K. H., Kautiainen, H., Tilvis, R. S., & Strandberg, T. E. (2010) · Drugs & Aging · doi:10.2165/11585060-000000000-00000 · Cited by 58
Bostock, C. V., Soiza, R. L., & Mangoni, A. A. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.34 · Cited by 58
Self-citationAntagonism by antidepressants of muscarinic acetylcholine receptors of human brain.
El‐Fakahany, E. E., & Richelson, E. (1983) · PubMed · Cited by 53
Kennedy, J. S., Bymaster, F. P., Schuh, L. M., Calligaro, D. O., Nomikos, G. G., Felder, C. C., Bernauer, M. J., Kinon, B. J., Baker, R. W., Hay, D. P., et al. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/1099-1166(200112)16:1+<::aid-gps571>3.0.co;2-5 · Cited by 45
Panula, J., Puustinen, J., Jaatinen, P. T., Vahlberg, T. J., Aarnio, P. T. T., & Kivelä, S. (2009) · Drugs & Aging · doi:10.2165/11317660-000000000-00000 · Cited by 43
Salpeter, S. R., & Buckley, N. S. (2006) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:31:2:219 · Cited by 36
Safety, tolerability and risk benefit analysis of tiotropium in COPD
Oba, Y., Zaza, & Thameem (2008) · International Journal of COPD · doi:10.2147/copd.s3530 · Cited by 33
Antipsychotics and Mortality in Parkinsonism
Marras, C., Gruneir, A., Wang, X., Fischer, H. D., Gill, S. S., Herrmann, N., Anderson, G., Hyson, C., & Rochon, P. A. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3182051bd6 · Cited by 33
Anticholinergics and central nervous system effects: are we confused?
Staskin, D. R., & Zoltan, E. (2007) · Europe PMC (PubMed Central) · Cited by 29
Rang, H. P., Dale, M. M., Ritter, J. M., Flower, R. J., & Henderson, G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3471-8.00013-5 · Cited by 4
Cited by
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
Hampel, H., Mesulam, M.-M., Cuello, A. C., Farlow, M. R., Giacobini, E., Grossberg, G. T., Khachaturian, A. S., Vergallo, A., Cavedo, E., Snyder, P. J., et al. (2018) · Brain · doi:10.1093/brain/awy132 · Cited by 1,918
Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews
Davies, L. E., Spiers, G., Kingston, A., Todd, A., Adamson, J., & Hanratty, B. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.10.022 · Cited by 544
Anticholinergics: theoretical and clinical overview
Nishtala, P. S., Salahudeen, M. S., & Hilmer, S. N. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1165664 · Cited by 167
Metadata
- Authors
- Ruxton, K., Woodman, R. J., & Mangoni, A. A.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2015-05-20
- Volume
- 80
- Issue
- 2
- Pages
- 209-220
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2155478022
- Cited by
- 360
- References
- 54
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.